Three-dimensional ultrasonography: an objective outcome tool to assess collagen distribution in women with stress urinary incontinence
- PMID: 12893325
- DOI: 10.1016/s0090-4295(03)00353-4
Three-dimensional ultrasonography: an objective outcome tool to assess collagen distribution in women with stress urinary incontinence
Abstract
Objectives: To examine the distribution of periurethral collagen by three-dimensional ultrasonography (3D US) and to incorporate this technology into a practical treatment decision tree for women with stress urinary incontinence desiring collagen injection.
Methods: Forty-six women who received periurethral collagen injection were assessed with 3D US to document the position and volume of collagen around the urethra. Patients with a good clinical response were observed with serial 3D US scans. Women with no persistent improvement who showed a low volume or asymmetric distribution of collagen were offered repeat injections. When the patient had no improvement despite symmetric or circumferential distribution of collagen with good volume retention, another anti-incontinence treatment was recommended. Group 1 was composed of women who had a good clinical outcome and group 2 of those who did not. A statistical comparison between the two outcome groups was done to determine whether any particular distribution pattern was associated with an increased likelihood of clinical success.
Results: Of the 46 patients, 21 (46%) were satisfied with their continence after their last periurethral collagen injection, with a median follow-up of 14.0 months (range 2 months to 4.25 years). A significantly greater proportion of patients in group 1 had circumferentially distributed collagen on 3D US compared with those in group 2 (62% versus 20%, P = 0.006).
Conclusions: Circumferential distribution of collagen around the urethra is associated with a higher likelihood of clinical success. The assessment of periurethral collagen by 3D US provides an affordable, noninvasive, objective outcome measure that may aid in treatment planning.
Similar articles
-
Three-dimensional endovaginal ultrasound examination following injection of Macroplastique for stress urinary incontinence: outcomes based on location and periurethral distribution of the bulking agent.Int Urogynecol J. 2013 Jul;24(7):1151-9. doi: 10.1007/s00192-012-1983-9. Epub 2012 Nov 15. Int Urogynecol J. 2013. PMID: 23229417
-
Three-dimensional ultrasonography to assess long-term durability of periurethral collagen in women with stress urinary incontinence due to intrinsic sphincter deficiency.Urology. 2005 Jan;65(1):60-4. doi: 10.1016/j.urology.2004.08.034. Urology. 2005. PMID: 15667864 Review.
-
Periurethral injection of collagen in the treatment of urinary stress incontinence: ultrasonographic appearance.Can Assoc Radiol J. 1995 Jun;46(3):189-93. Can Assoc Radiol J. 1995. PMID: 7538878
-
Durability of collagen injection for stress urinary incontinence in women proven by transvaginal 3-dimensional ultrasound.Female Pelvic Med Reconstr Surg. 2015 Jan-Feb;21(1):25-9. doi: 10.1097/SPV.0000000000000094. Female Pelvic Med Reconstr Surg. 2015. PMID: 25185619
-
Role of three-dimensional ultrasound in assessment of women undergoing urethral bulking agent therapy.Curr Opin Obstet Gynecol. 2004 Oct;16(5):411-7. doi: 10.1097/00001703-200410000-00010. Curr Opin Obstet Gynecol. 2004. PMID: 15353951 Review.
Cited by
-
Materials Selection for the Injection into Vaginal Wall for Treatment of Vaginal Atrophy.Aesthetic Plast Surg. 2021 Jun;45(3):1231-1241. doi: 10.1007/s00266-020-02054-w. Epub 2021 Mar 1. Aesthetic Plast Surg. 2021. PMID: 33649927 Review.
-
Three-dimensional endovaginal ultrasound examination following injection of Macroplastique for stress urinary incontinence: outcomes based on location and periurethral distribution of the bulking agent.Int Urogynecol J. 2013 Jul;24(7):1151-9. doi: 10.1007/s00192-012-1983-9. Epub 2012 Nov 15. Int Urogynecol J. 2013. PMID: 23229417
-
Imaging findings of vinyl dimethyl polydimethylsiloxane used as a paraurethral injectable for female stress urinary incontinence.Ther Adv Urol. 2021 Dec 5;13:17562872211060909. doi: 10.1177/17562872211060909. eCollection 2021 Jan-Dec. Ther Adv Urol. 2021. PMID: 35173814 Free PMC article.
-
Volume changes and histological response to injected dextranomer/hyaluronic acid copolymer (Zuidex) and collagen (Contigen) in rats.Int Urogynecol J Pelvic Floor Dysfunct. 2008 Feb;19(2):247-52. doi: 10.1007/s00192-007-0414-9. Epub 2007 Jul 17. Int Urogynecol J Pelvic Floor Dysfunct. 2008. PMID: 17639343
-
Current use of injectable agents for female stress urinary incontinence.Rev Urol. 2005;7 Suppl 1(Suppl 1):S12-21. Rev Urol. 2005. PMID: 16985872 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical